Replies to post #332307 on Avid Bioservices Inc (CDMO)

[biopharm]

There are some NEW IIS with information on PS Targeting and Avid CDMO plans that some usually don't see till it is too late to buy in somewhat early

Too late in this may be, buying this in $5 range vs $20 range and many that do buy in $20 range will not settle for a $20 buyout depending upon Ampersand Capital plans

When other news flows, shareholders may demand 100% open access to all sealed court documents and all prior collaborations and ALL nondisclosure agreements signed

We may even have to see a surprise deposition from William Jay Treat or BARDA or Bone Biologics or many others ...

PS Targeting the Microsoft of Biotechnology as CP said ? Maybe that was on target